{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T23:47:03Z","timestamp":1786924023999,"version":"build-2736575974"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["PAC-SCSM-RPS-ICMR-1436"],"award-info":[{"award-number":["PAC-SCSM-RPS-ICMR-1436"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["PAC-SCSM-HRK-ICMR-1435"],"award-info":[{"award-number":["PAC-SCSM-HRK-ICMR-1435"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["PAC-SCSM-HRK-ICMR-04220423-1440"],"award-info":[{"award-number":["PAC-SCSM-HRK-ICMR-04220423-1440"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/2021-22\/JNU\/1844"],"award-info":[{"award-number":["DBT\/2021-22\/JNU\/1844"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/2021-22\/JNU\/1862"],"award-info":[{"award-number":["DBT\/2021-22\/JNU\/1862"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbadis.2024.167563","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T02:46:16Z","timestamp":1730774776000},"page":"167563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Linking COVID-19 and cancer: Underlying mechanism"],"prefix":"10.1016","volume":"1871","author":[{"given":"Sourabh","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipanshi","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awantika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelja","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant Ritturaj","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167563_bb0005","author":"World Health Organization"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167563_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0015","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"18","key":"10.1016\/j.bbadis.2024.167563_bb0020","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.7150\/jca.49462","article-title":"Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167563_bb0025","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.annonc.2020.04.479","article-title":"Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)","volume":"31","author":"Montopoli","year":"2020","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cncr.33243","article-title":"Multivariate mortality analyses in COVID-19: comparing patients with cancer and patients without cancer in Louisiana","volume":"127","author":"Lunski","year":"2021","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167563_bb0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.annonc.2020.04.006","article-title":"Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City","volume":"31","author":"Miyashita","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2018.08.010","article-title":"Immune-based therapeutic approaches to virus-associated cancers","volume":"32","author":"Smith","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102041","article-title":"Cancer and COVID-19: unmasking their ties","volume":"88","author":"Addeo","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"10241","key":"10.1016\/j.bbadis.2024.167563_bb0050","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0055","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","article-title":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","article-title":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes","volume":"5","author":"Shi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2024.167563_bb0075","series-title":"The Nalp3 Inflammasome Is Essential for the Development of Silicosis","author":"Cassel","year":"2008"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167563_bb0080","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1074\/jbc.M608083200","article-title":"ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages","volume":"282","author":"Cruz","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2024.167563_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167563_bb0090","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes?","volume":"29","author":"Wang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167563_bb0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"51","key":"10.1016\/j.bbadis.2024.167563_bb0100","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1038\/sj.onc.1209938","article-title":"Current insights into the regulation of programmed cell death by NF-kappaB","volume":"25","author":"Dutta","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2024.167563_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.871583","article-title":"p53\/NF-kB balance in SARS-CoV-2 infection: from OMICs, genomics and pharmacogenomics insights to tailored therapeutic perspectives (COVIDomics)","volume":"13","author":"Milani","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.574753","article-title":"ACE2, COVID-19 infection, inflammation, and coagulopathy: missing pieces in the puzzle","volume":"11","author":"Abassi","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112420","article-title":"Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets","volume":"145","author":"Farahani","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0120","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2208679","article-title":"The unreversible reduced but persistent activated NK and CD8+ T cells in severe\/critical COVID-19 during omicron pandemic in China","volume":"12","author":"Qin","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"55","key":"10.1016\/j.bbadis.2024.167563_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe4782","article-title":"Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells","volume":"6","author":"Kusnadi","year":"2021","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: immunopathogenesis and Immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3892\/ijo.2016.3632","article-title":"The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6\/JAK\/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer","volume":"49","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0140","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/leu.2017.103","article-title":"PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma","volume":"31","author":"Atsaves","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gutjnl-2016-311585","article-title":"IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer","volume":"67","author":"Mace","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0150","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167563_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/2050312121991246","article-title":"Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: a cross-sectional comparative study in Jigawa, Northwestern Nigeria","volume":"9","author":"Muhammad","year":"2021","journal-title":"SAGE Open Med."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0160","doi-asserted-by":"crossref","first-page":"C57","DOI":"10.1152\/ajpcell.00426.2020","article-title":"Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19","volume":"320","author":"Ajaz","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0165","article-title":"SARS-CoV-2 activates ER stress and unfolded protein response","author":"Rosa-Fernandes","year":"2021","journal-title":"Biorxiv"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-021-00268-z","article-title":"The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Discov."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109126","article-title":"Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities","volume":"35","author":"Hayn","year":"2021","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167563_bb0180","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1080\/15548627.2021.1953847","article-title":"Manipulation of autophagy by SARS-CoV-2 proteins","volume":"17","author":"Koepke","year":"2021","journal-title":"Autophagy"},{"issue":"22","key":"10.1016\/j.bbadis.2024.167563_bb0185","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3390\/cancers13225721","article-title":"Autophagy: the potential link between SARS-CoV-2 and cancer","volume":"13","author":"Habibzadeh","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2024.167563_bb0190","article-title":"An unexpected tumor suppressor role of SQSTM1\/p62 in liver tumorigenesis","author":"Chao","year":"2021","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0195","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/gut.2009.194472","article-title":"Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer","volume":"59","author":"Simpson","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0200","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167563_bb0205","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0210","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1158\/2159-8290.CD-20-0559","article-title":"The landscape of human cancer proteins targeted by SARS-CoV-2","volume":"10","author":"Tutuncuoglu","year":"2020","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.bbadis.2024.167563_bb0215","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1128\/MCB.00204-12","article-title":"Histone methyltransferase NSD2\/MMSET mediates constitutive NF-\u03baB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop","volume":"32","author":"Yang","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"6504","key":"10.1016\/j.bbadis.2024.167563_bb0220","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbadis.2024.167563_bb0225","article-title":"Review Devil's tools: SARS-CoV-2 antagonists against innate immunity","volume":"2","author":"Xu","year":"2021","journal-title":"Curr. Res. Virol. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0230","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41467-023-36140-9","article-title":"Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2","volume":"14","author":"Venet","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28122","article-title":"COVID-19 immunopathology: from acute diseases to chronic sequelae","volume":"95","author":"Arish","year":"2023","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167563_bb0240","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2024.167563_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbadis.2024.167563_bb0250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2020.05.007","article-title":"p38 MAPK inhibition: a promising therapeutic approach for COVID-19","volume":"144","author":"Grimes","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0255","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ddr.21674","article-title":"COVID-19 transmission through host cell directed network of GPCR","volume":"81","author":"Singh","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bbadis.2024.167563_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.681948","article-title":"The notch pathway: a link between COVID-19 pathophysiology and its cardiovascular complications","volume":"8","author":"Breikaa","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0265","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/cells9061503","article-title":"Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives","volume":"9","author":"Moore","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2024.167563_bb0270","article-title":"Identification of common key genes and pathways between Covid-19 and lung cancer by using protein-protein interaction network analysis","author":"Nan","year":"2021","journal-title":"bioRxiv"},{"issue":"35","key":"10.1016\/j.bbadis.2024.167563_bb0275","doi-asserted-by":"crossref","first-page":"E5192","DOI":"10.1073\/pnas.1603435113","article-title":"p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1","volume":"113","author":"Ma-Lauer","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167563_bb0280","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1128\/JVI.07012-11","article-title":"The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein","volume":"86","author":"Bhardwaj","year":"2012","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167563_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100814","article-title":"S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study","volume":"13","author":"Singh","year":"2020","journal-title":"Transl. Oncol."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167563_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108175","article-title":"A single-cell RNA expression map of human coronavirus entry factors","volume":"32","author":"Singh","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2024.167563_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.578599","article-title":"Mitochondria targeted viral replication and survival strategies-prospective on SARS-CoV-2","volume":"11","author":"Gatti","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"7816","key":"10.1016\/j.bbadis.2024.167563_bb0300","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0305","first-page":"3080","article-title":"SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome","volume":"193","author":"Shi","year":"2014","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167563_bb0310","first-page":"1278","article-title":"The role of mitochondrial dynamics in human cancers","volume":"10","author":"Ma","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167563_bb0315","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(20)30230-8","article-title":"The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19","volume":"21","author":"UK Coronavirus Cancer Monitoring Project team","year":"2020","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0320","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jnci\/djaa159","article-title":"Prevalence and outcome of COVID-19 infection in cancer patients: a National Veterans Affairs Study","volume":"113","author":"Fillmore","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2024.167563_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2021.08.1577","article-title":"1584P prevalence and risk factors of COVID-19 in cancer patients: a prospective monocentric study","volume":"32","author":"Ben Kridis","year":"2021","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0330","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study","volume":"21","author":"Tian","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0335","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.2147\/CMAR.S272008","article-title":"The landscape of COVID-19 in cancer patients: prevalence, impacts, and recommendations","volume":"12","author":"Abdihamid","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167563_bb0340","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/j.clon.2020.10.021","article-title":"Estimating the risk of death from COVID-19 in adult cancer patients","volume":"33","author":"Williams","year":"2021","journal-title":"Clin. Oncol. (R. Coll. Radiol. (Great Britain))"},{"key":"10.1016\/j.bbadis.2024.167563_bb0345","article-title":"Epidemiology and clinical course of SARS-CoV-2 infection in cancer patients in the Veneto Oncology Network during the first and second pandemic waves","volume":"39","author":"Valentina Guarneri","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167563_bb0350","doi-asserted-by":"crossref","first-page":"e1656","DOI":"10.1002\/onco.13831","article-title":"COVID-19 in patients with cancer: a retrospective study of 212 cases from a French SARS-CoV-2 cluster during the first wave of the COVID-19 pandemic","volume":"26","author":"Martin","year":"2021","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.seminoncol.2021.01.002","article-title":"Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: an Andalusian cohort study","volume":"48","author":"Mart\u00edn-Bravo","year":"2021","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0360","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2021.01.001","article-title":"Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients","volume":"39","author":"Abdul-Jawad","year":"2021","journal-title":"Cancer cell"},{"issue":"10","key":"10.1016\/j.bbadis.2024.167563_bb0365","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0370","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2020-141871","article-title":"COVID-19 impact on lymphoma patients\u2019 clinical outcomes - an observational cohort study","volume":"136","author":"Ip","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0375","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","article-title":"Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies","volume":"12","author":"Lee","year":"2022","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0380","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2024.167563_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2021.03.033","article-title":"Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients","volume":"150","author":"Mansi","year":"2021","journal-title":"Eur. J. Cancer (Oxford, England : 1990)"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167563_bb0390","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1158\/2159-8290.CD-21-0191","article-title":"Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in patients with cancer","volume":"11","author":"Bilich","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100943","article-title":"Lymphocyte subsets in haematological patients with COVID-19: multicentre prospective study","volume":"14","author":"Kalici\u0144ska","year":"2021","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0400","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41571-020-00441-5","article-title":"COVID-19 in patients with cancer: managing a pandemic within a pandemic","volume":"18","author":"Horn","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30150-9","article-title":"Risk of COVID-19 for patients with cancer","volume":"21","author":"Xia","year":"2020","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0415","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2024.167563_bb0420","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720968749","article-title":"ACE2 and TMPRSS2 potential involvement in genetic susceptibility to SARS-COV-2 in cancer patients","volume":"29","author":"Ravaioli","year":"2020","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0425","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12935-021-02129-x","article-title":"Gastrointestinal cancers, ACE-2\/TMPRSS2 expression and susceptibility to COVID-19","volume":"21","author":"Shafiee","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2024.167563_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.594928","article-title":"Analysis of Indian SARS-CoV-2 genomes reveals prevalence of D614G mutation in spike protein predicting an increase in interaction with TMPRSS2 and virus infectivity","volume":"11","author":"Raghav","year":"2020","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167563_bb0435","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7150\/ijbs.54055","article-title":"Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19","volume":"17","author":"Fu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167563_bb0440","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/2211-5463.12984","article-title":"An investigation into the molecular basis of cancer comorbidities in coronavirus infection","volume":"10","author":"Facchiano","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"14","key":"10.1016\/j.bbadis.2024.167563_bb0445","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.7150\/ijbs.63072","article-title":"COVID-19 disease and malignant cancers: the impact for the furin gene expression in susceptibility to SARS-CoV-2","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0450","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3892\/etm.2023.12340","article-title":"Comprehensive analysis and immunohistochemistry localization of NRP1 expression in pancancer and normal individual tissues in relation to SARS-CoV-2 susceptibility","volume":"27","author":"Fu","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167563_bb0455","first-page":"1711","article-title":"High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma","volume":"19","author":"Luo","year":"2020","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167563_bb0460","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/ijo.2023.5489","article-title":"Effect of DPP4\/ CD26 expression on SARS-CoV-2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals","volume":"62","author":"Du","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0465","article-title":"Comprehensive and integrative analysis of two novel SARS-CoV-2 entry associated proteases CTSB and CTSL in healthy individuals and cancer patients","volume":"10","author":"Huang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0470","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.18632\/aging.205655","article-title":"A comprehensive investigation on the receptor BSG expression reveals the potential risk of healthy individuals and cancer patients to 2019-nCoV infection","volume":"16","author":"Huang","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0475","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"45","key":"10.1016\/j.bbadis.2024.167563_bb0480","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0485","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.annonc.2020.03.001","article-title":"Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19","volume":"31","author":"Qu","year":"2020","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0490","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cgt.2015.11","article-title":"Oncolytic viruses: focusing on the tumor microenvironment","volume":"22","author":"de Vries","year":"2015","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0500","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/molecules25071618","article-title":"Role of the neutrophil in the pathogenesis of advanced cancer and impaired responsiveness to therapy","volume":"25","author":"Rapoport","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0505","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/rb\/rbw041","article-title":"An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration","volume":"4","author":"Selders","year":"2017","journal-title":"Regen. Biomater."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0510","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102536","article-title":"ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia","volume":"19","author":"Rivellese","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0520","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","article-title":"ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0525","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2016.04.006","article-title":"Downregulation of ACE2\/Ang-(1-7)\/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry","volume":"376","author":"Yu","year":"2016","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167563_bb0530","first-page":"1198","article-title":"SARS-CoV-2 as a factor to disbalance the renin-angiotensin system: a suspect in the case of exacerbated IL-6 production","volume":"205","author":"Franco","year":"2020","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167563_bb0535","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0540","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and specificity: insights from the interleukin 6 family of cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2024.167563_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.685196","article-title":"Changes in glycolytic pathway in SARS-COV 2 infection and their importance in understanding the severity of COVID-19","volume":"9","author":"Santos","year":"2021","journal-title":"Front. Chem."},{"issue":"18","key":"10.1016\/j.bbadis.2024.167563_bb0550","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/1873-3468.14180","article-title":"Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production","volume":"595","author":"Yaneske","year":"2021","journal-title":"FEBS Lett."},{"issue":"7816","key":"10.1016\/j.bbadis.2024.167563_bb0555","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","article-title":"Proteomics of SARS-CoV-2-infected host cells reveals therapy targets","volume":"583","author":"Bojkova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167563_bb0560","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the regulation of tumor microenvironment and therapeutic approaches","volume":"9","author":"de la Cruz-L\u00f3pez","year":"2019","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2024.167563_bb0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried","year":"2013","journal-title":"Crit. Rev. Oncog."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0570","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"issue":"6409","key":"10.1016\/j.bbadis.2024.167563_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0580","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/cells9071619","article-title":"Canonical and noncanonical autophagy as potential targets for COVID-19","volume":"9","author":"Bello-Perez","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0585","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/biores.2014.0035","article-title":"Autophagy in cancer stem cells: a potential link between chemoresistance, recurrence, and metastasis","volume":"4","author":"Ojha","year":"2015","journal-title":"BioRes. Open Access"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167563_bb0590","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4161\/cc.10.11.15674","article-title":"Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator","volume":"10","author":"Martinez-Outschoorn","year":"2011","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.bbadis.2024.167563_bb0595","doi-asserted-by":"crossref","first-page":"967","DOI":"10.5005\/jp-journals-10071-23547","article-title":"Mechanisms of hypoxia in COVID-19 patients: a pathophysiologic reflection","volume":"24","author":"Nitsure","year":"2020","journal-title":"Indian J. Crit. Care Med."},{"key":"10.1016\/j.bbadis.2024.167563_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 vaccine: a comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0605","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41571-022-00610-8","article-title":"COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety","volume":"19","author":"Fendler","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0610","article-title":"Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium","volume":"19","author":"Choueiri","year":"2023","journal-title":"Lancet Reg. Health Am."},{"issue":"13","key":"10.1016\/j.bbadis.2024.167563_bb0615","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1200\/JCO.21.02419","article-title":"Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative","volume":"40","author":"Song","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0620","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(22)00202-9","article-title":"Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study","volume":"23","author":"Lee","year":"2022","journal-title":"Lancet Oncol."},{"issue":"22","key":"10.1016\/j.bbadis.2024.167563_bb0625","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.3390\/cancers14225630","article-title":"Cancer patients and the COVID-19 vaccines: considerations and challenges","volume":"14","author":"Almasri","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167563_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281907","article-title":"A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA","volume":"18","author":"Rachman","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0635","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41541-022-00478-w","article-title":"Rational development of a combined mRNA vaccine against COVID-19 and influenza","volume":"7","author":"Ye","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167563_bb0640","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2024.167563_bb0645","first-page":"1321","article-title":"Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study","volume":"2","author":"Fendler","year":"2021","journal-title":"Nat. Can."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167563_bb0650","first-page":"3086","article-title":"Influenza and pneumococcal vaccination and the risk of COVID-19: a systematic review and meta-analysis","volume":"12","author":"Kapoula","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"17","key":"10.1016\/j.bbadis.2024.167563_bb0655","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","article-title":"Randomized trial of BCG vaccine to protect against Covid-19 in health care workers","volume":"388","author":"Pittet","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2024.167563_bb0660","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820002125","article-title":"Ecologic association between influenza and COVID-19 mortality rates in European countries","volume":"148","author":"Petti","year":"2020","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0665","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jmv.26120","article-title":"Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy","volume":"93","author":"Mar\u00edn-Hern\u00e1ndez","year":"2021","journal-title":"J. Med. Virol."},{"issue":"21","key":"10.1016\/j.bbadis.2024.167563_bb0670","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.3390\/ijerph17217870","article-title":"The association between influenza vaccination and the risk of SARS-CoV-2 infection, severe illness, and death: a systematic review of the literature","volume":"17","author":"Del Riccio","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29343","article-title":"Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: a systematic review and meta-analysis","volume":"96","author":"Pontiroli","year":"2024","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0680","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.vaccine.2022.12.043","article-title":"Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity","volume":"41","author":"Xie","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.bbadis.2024.167563_bb0685","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-101819-074948","article-title":"Natural killer cells: from innate to adaptive features","volume":"39","author":"Mujal","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167563_bb0690","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/vaccines12070731","article-title":"Influenza vaccination mediates SARS-CoV-2 spike protein peptide-induced inflammatory response via modification of histone acetylation","volume":"12","author":"Zuo","year":"2024","journal-title":"Vaccines"},{"issue":"10318","key":"10.1016\/j.bbadis.2024.167563_bb0695","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","article-title":"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial","volume":"398","author":"Lazarus","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167563_bb0700","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2213-2600(21)00409-4","article-title":"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial","volume":"10","author":"Toback","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"35","key":"10.1016\/j.bbadis.2024.167563_bb0705","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.vaccine.2016.06.064","article-title":"Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: a systematic review and meta-analysis of randomised controlled trials","volume":"34","author":"Moa","year":"2016","journal-title":"Vaccine"},{"issue":"10318","key":"10.1016\/j.bbadis.2024.167563_bb0710","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbadis.2024.167563_bb0715","article-title":"Timing and sequence of vaccina\/ tion against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial","volume":"29","author":"Dulfer","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0720","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-021-00618-z","article-title":"Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza","volume":"6","author":"Bao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0725","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01390-2022","article-title":"Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination","volume":"61","author":"Wagenh\u00e4user","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbadis.2024.167563_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105103","article-title":"Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses","volume":"103","author":"Pattinson","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167563_bb0735","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01578-21","article-title":"A single vaccine protects against SARS-CoV-2 and influenza virus in mice","volume":"96","author":"Cao","year":"2022","journal-title":"J. Virol."},{"issue":"Supplement_2","key":"10.1016\/j.bbadis.2024.167563_bb0740","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac492.1762","article-title":"2142. Safety and immunogenicity of COVID influenza combination vaccine","volume":"9","author":"Shinde","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167563_bb0745","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2023.11.057","article-title":"Transformative vaccination: a pentavalent shield against COVID-19 and influenza with betulin-based adjuvant for enhanced immunity","volume":"42","author":"Krasilnikov","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167563_bb0750","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41541-024-00857-5","article-title":"An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza","volume":"9","author":"Xing","year":"2024","journal-title":"NPJ Vaccines"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392400557X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392400557X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:27:25Z","timestamp":1768354045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392400557X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S092544392400557X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167563","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking COVID-19 and cancer: Underlying mechanism","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167563"}}